Cell line name | HeLa BU-25 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | HeLa (BU-25); HeLa BU25; HeLa Bu25; HeLa/BU-25; HeLa(BU25); HeLa TK- (BU 25); Bu25 TK-; BU25 TK-; Bu25TK- | ||||||||||||||||||
Accession | CVCL_2320 | ||||||||||||||||||
Resource Identification Initiative | To cite this cell line use: HeLa BU-25 (RRID:CVCL_2320) | ||||||||||||||||||
Comments | Population: African American. Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR). Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Omics: SNP array analysis. Derived from sampling site: Uterus; cervix. | ||||||||||||||||||
Disease | Human papillomavirus-related endocervical adenocarcinoma (NCIt: C27677) | ||||||||||||||||||
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
| ||||||||||||||||||
Hierarchy | Parent: CVCL_0058 (HeLa S3) | ||||||||||||||||||
Sex of cell | Female | ||||||||||||||||||
Age at sampling | 30Y6M | ||||||||||||||||||
Category | Cancer cell line | ||||||||||||||||||
STR profile | Source(s): ECACC; RCB Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||
Publications | PubMed=5902315; DOI=10.1002/ijc.2910010105 PubMed=4639815; DOI=10.1016/0006-291X(72)90519-0 PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458 | ||||||||||||||||||
Cross-references | |||||||||||||||||||
Cell line collections | ECACC; 85022104
RCB; RCB0205 | ||||||||||||||||||
Cell line databases/resources | CLO; CLO_0002050
CLO; CLO_0050929 CLDB; cl506 | ||||||||||||||||||
Encyclopedic resources | Wikidata; Q54882520 | ||||||||||||||||||
Gene expression databases | GEO; GSM827315 | ||||||||||||||||||
Polymorphism and mutation databases | Cosmic; 753537
Progenetix; CVCL_2320 | ||||||||||||||||||
Entry history | |||||||||||||||||||
Entry creation | 04-Apr-2012 | ||||||||||||||||||
Last entry update | 29-Oct-2020 | ||||||||||||||||||
Version number | 15 |